Cargando…

Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States

INTRODUCTION: Pembrolizumab was approved in the US as adjuvant treatment of patients with stage IIB or IIC melanoma post-complete resection, based on prolonged recurrence-free survival vs. placebo in the Phase 3 KEYNOTE-716 trial. This study aimed to evaluate the cost-effectiveness of pembrolizumab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Shujing, Bensimon, Arielle G., Xu, Ruifeng, Jiang, Ruixuan, Greatsinger, Alexandra, Zhang, Adina, Fukunaga-Kalabis, Mizuho, Krepler, Clemens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10271902/ https://www.ncbi.nlm.nih.gov/pubmed/37191852 http://dx.doi.org/10.1007/s12325-023-02525-x

Ejemplares similares

An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA
por: Bensimon, Arielle G., et al.
Publicado: (2020)

A randomised trial evaluating bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma: an update
por: Biswas, S, et al.
Publicado: (2008)

Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection
por: Lopez-Vinueza, Cesar, et al.
Publicado: (2023)

An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanoma
por: Lorenzi, Maria, et al.
Publicado: (2019)

From cancer stem cells to tumor maintenance in melanoma
por: Fukunaga-Kalabis, Mizuho, et al.
Publicado: (2011)

Re-Evaluation of the Survival Paradox Between Stage IIB/IIC and Stage IIIA Colon Cancer
por: Li, Hongbo, et al.
Publicado: (2020)

Matricellular Proteins Produced by Melanocytes and Melanomas: In Search for Functions
por: Fukunaga-Kalabis, Mizuho, et al.
Publicado: (2008)

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
por: Li, Ling, et al.
Publicado: (2011)

Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma
por: Krepler, Clemens, et al.
Publicado: (2016)

The Divergent CD8(+) T Cell Adjuvant Properties of LT-IIb and LT-IIc, Two Type II Heat-Labile Enterotoxins, Are Conferred by Their Ganglioside-Binding B Subunits
por: Hu, John C., et al.
Publicado: (2015)

Pembrolizumab Utilization and Clinical Outcomes Among Patients With Advanced Melanoma in the US Community Oncology Setting: An Updated Analysis
por: Cowey, Charles Lance, et al.
Publicado: (2021)

What is the optimal surgical treatment for Neer type IIB (IIC) distal clavicle fractures? A systematic review and meta-analysis
por: Panagopoulos, Andreas, et al.
Publicado: (2022)

Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB–IIIB resectable lung squamous cell carcinoma
por: Shen, Dijian, et al.
Publicado: (2021)

Studies of the expression of the cytochrome P450IA, P450IIB, and P450IIC gene family in extrahepatic and hepatic tissues.
por: Friedberg, T, et al.
Publicado: (1990)

DDA1 promotes stage IIB–IIC colon cancer progression by activating NFκB/CSN2/GSK-3β signaling
por: Zhao, Senlin, et al.
Publicado: (2016)

Adjuvant Therapy of High-Risk (Stages IIC–IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis
por: Christofyllakis, Konstantinos, et al.
Publicado: (2021)

Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
por: Brokāne, Linda, et al.
Publicado: (2019)

Prior Therapy With Pegylated-Interferon Alfa-2b Improves the Efficacy of Adjuvant Pembrolizumab in Resectable Advanced Melanoma
por: Jia, Dong-Dong, et al.
Publicado: (2021)

Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population
por: Fukunaga-Kalabis, Mizuho, et al.
Publicado: (2010)

Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins
por: Lee, Jooyoung, et al.
Publicado: (2018)

Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4
por: Li, Xuzichao, et al.
Publicado: (2023)

Cost-Effectiveness of Pembrolizumab for the Adjuvant Treatment of Melanoma Patients with Lymph Node Involvement Who Have Undergone Complete Resection in Argentina
por: Wurcel, Victoria, et al.
Publicado: (2021)

Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial
por: Kirkwood, John M., et al.
Publicado: (2023)

Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
por: Mohr, Peter, et al.
Publicado: (2022)

Periodontal Microsurgical-Assisted Pouch and Tunnel Approach in Combination with Subepithelial Connective Tissue Graft for the Management of Class IIB and IIC Multiple Adjacent Gingival Recessions in Mandibular Anterior Segment
por: Salaria, Sanjeev Kumar, et al.
Publicado: (2018)

NUMB as a Therapeutic Target for Melanoma
por: Hristova, Denitsa M., et al.
Publicado: (2022)

Unilateral transnasal endoscopic approach to frontal sinuses: Draf IIc
por: Al Komser, Mohammed K., et al.
Publicado: (2013)

A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
por: Vreeland, Timothy J., et al.
Publicado: (2021)

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study
por: Mordoh, José, et al.
Publicado: (2017)

Intradermal Administration of the Type II Heat-Labile Enterotoxins LT-IIb and LT-IIc of Enterotoxigenic Escherichia coli Enhances Humoral and CD8(+) T Cell Immunity to a Co-Administered Antigen
por: Hu, John C., et al.
Publicado: (2014)

Transitions between the steps of forward and reverse splicing of group IIC introns
por: Smathers, Claire M., et al.
Publicado: (2020)

A redox switch regulates the assembly and anti-CRISPR activity of AcrIIC1
por: Zhao, Yanan, et al.
Publicado: (2022)

CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1
por: Fukunaga-Kalabis, Mizuho, et al.
Publicado: (2006)

The clinical impact of preoperative biliary drainage on isolated infectious complications (iiC) after pancreatic head resection—a retrospective study
por: Krueger, Colin M., et al.
Publicado: (2022)

Case Report: Hemophagocytic Lymphocytosis in a Patient With Glutaric Aciduria Type IIC
por: Huang, Lingtong, et al.
Publicado: (2022)

Spotlight on pembrolizumab in the treatment of advanced melanoma
por: Rajakulendran, Thanashan, et al.
Publicado: (2015)

Case Report: Pathologic Complete Response to Pembrolizumab in Combination With Neoadjuvant Chemotherapy in a Patient With Stage IIB Squamous Lung Cancer
por: Zhang, Lin, et al.
Publicado: (2020)

Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer
por: Yamaguchi, Kensei, et al.
Publicado: (2022)

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial
por: Eggermont, Alexander M. M., et al.
Publicado: (2020)

Activation of actin polymerization by phosphatidic acid derived from phosphatidylcholine in IIC9 fibroblasts
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_c8frokhojc8danrmqkvvuar5rh